Η Γραμματεία δέχεται τους φοιτητές όλες τις εργάσιμες ημέρες κατά τις ώρες 12:00 – 13:30.

Email: pharminf@upatras.gr
Τηλ: 2610962300

Διεύθυνση:
Γραμματεία Τμήματος Φαρμακευτικής
Πανεπιστημιούπολη
Ρίον Αχαϊας
 26504

sfe

Χάρτης

ΟΔΗΓΟΣ ΣΠΟΥΔΩΝ Ακαδημαϊκού Έτους 2017-2018

Κατάσταση Συγγραμμάτων 2017-2018

Διανομή Υγρού Αζώτου

Γρήγορες Πληροφορίες

  • Δείτε τα ωρολόγια προγράμματα (προπτυχιακών και μεταπτυχιακών σπουδών) του τρέχοντος ακαδημαϊκού έτους.

    Ωρολόγιο Πρόγραμμα

  • Επαγγελματικά Νέα, Ευκαιρίες Απασχόλησης στην Έρευνα και Εργασία για Απόφοιτους Φαρμακευτικής

     

Χρήσιμα

  • Απαραίτητα δικαιολογητικά και ημερομηνίες εγγραφών

     

  • Ένας σύντομος οδηγός για τις πρώτες ενέργειες των πρωτοετών φοιτητών

    Πρωτοετείς Φοιτητές

  • Κατεβάστε σε ηλεκτρονική μορφή την αίτηση που σας ενδιαφέρει

    Έντυπα

  • Διαβάστε το τελευταίο ή παλαιότερα ενημερωτικά δελτία

     

Σωτηροπούλου Γεωργία
Tel. : (+302610) 962315 | 962316
Fax : (+302610) 997697
E-mail: Αυτή η διεύθυνση ηλεκτρονικού ταχυδρομείου προστατεύεται από κακόβουλη χρήση. Χρειάζεται να ενεργοποιήσετε την Javascript για να τη δείτε.

Education

1987 : Ph.D. in Biochemistry, Aristotle University of Thessaloniki, Greece
1980 : Diploma in Chemistry, University of Patras, Greece

Research Training

1998 : Cancer Biology (Prof. AB Pardee), Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA, USA.
1993-1995 : Cancer Genetics (Prof. Ruth Sager), Dana-Farber Cancer Institute/Harvard Medical School, Boston, MA, USA.
1988-1989 : The Institute of Physical and Chemical Research RIKEN, Saitama, Japan
1981-1987 : The National Research Center "Demokritos", Athens, Greece

Professional Appointments

2003 : Associate Professor, Department of Pharmacy, School of Health Sciences, University of Patras, Greece
1998 : Sabbatical training (c/o Prof Arthur B. Pardee), Division of Cancer Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA Fulbright Senior Research Award (1998)
1993 : Assistant Professor, Department of Pharmacy, School of Health Sciences, University of Patras, Greece
1993 : Sabbatical training (c/o Prof Ruth Sager) Division of Cancer Genetics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA Fulbright Senior Research Award (1993)
1989 : Lecturer, Department of Pharmacy, School of Health Sciences, University of Patras, Greece
1988-1989 : Invited Research Scientist, The Institute of Physical and Chemical Research, RIKEN, Japan.
1987-1988 : Postdoctoral Fellow, Institute of Biology, NCSR "Demokritos", Greece and Laboratory of Enzymatic Technology, Technological University of Compiegne, Compiegne, France (c/o Prod Daniel Thomas)
1985 : Short-term visitor, Dept. of Biophysics, University of Osnabruck, Germany (c/o Prof Wolfgang Junge)
1981-1987 : Graduate Research Fellow, Institute of Biology, Laboratory of Biochemistry and Biophysics of Biological Membranes, National Center for Scientific Research (NCSR) "Demokritos", Aghia Paraskevi, Attiki, Greece (c/o Dr George C. Papageorgiou)


Research Interests

  • Cancer invasion and metastasis: molecular mechanisms, diagnostic and drug targets. Tumor suppressor genes and proteins. Differential gene expression in cancer: methodologies, diagnostic and therapeutic implications.
  • Pharmacological unmasking of epigenetically silenced tumor suppressor genes in human cancers.
  • Molecular mechanisms underlying anti-cancer drug resistance.
  • Proteases and protease inhibitors. The human kallikrein gene family.
  • Tumor biomarkers.
  • Cellular senescence.
  • Production and engineering of recombinant proteins.

Funding
  • PENED2003-Greek Secretariat of Research & Technology (2006-2008) “Study of the function and transcriptional regulation of kallikrein 6 in human tumors-Analysis of DNA methylation of the KLK6 gene for the molecular diagnosis of cancer-Identification of specific substrates, synthesis and validation of specific and selective inhibitors” (03ED43)
  • PENED2001-Greek Secretariat of Research & Technology (2002-2005) “Development and evaluation of novel diagnostics for the molecular diagnosis and staging of cancer” (01ED557)
  • PENED2001-Greek Secretariat of Research & Technology (2002-2005) “Immunomodulation of the expression of HER-2 (c-erbB2) by administra-tion of IFN-γ, in patients receiving the monoclonal antibody Trastuzumab for metastatic breast cancer” (01ED475)
  • Research Grant provided by the Mount Sinai Hospital, Toronto, Ontario, Canada (2002-2003) “Production and biochemical characterization of recombinant human kallikreins”
  • PENED 1999-Greek Secretariat of Research & Technology (2000-2001) “Pathophysiology of bone metastasis from hormone-dependent cancers (prostate-breast): The role of urokinase and protease M-Design of specific and selective inhibitors for urokinase and protease M”
  • NATO Collaborative Research Grant (1998-2000) “Characterization of selected proteases from human normal and tumor cells”
  • K. Karatheodoris Grant Research Committee of the University of Patras (1998-2001)
  • Fulbright Senior Research Award (1998) “In vivo and in vitro assays for drug discovery-Functional evaluation of cystatin M as a tumor suppressor by the nude mouse assay. Development of an in vitro assay for screening anticancer drugs using the expression of the green fluorescent protein as a marker”
  • Fulbright Senior Research Award (1993) “Identification and characterization of molecular markers for cancer. Isolation of anti-peptide antibodies based on the identified markers”

Teaching

Undergraduate Cources:
  • Cellular Biology (lectures, 4h/week), 2nd semester
  • Molecular Biology and Genetics (lectures, 3h/week and practical 3h/week), 4th semester
  • Pharmaceutical Biotechnology (lectures 4h/week, and practical 3h/week), 7th semester
Postgraduate Cources:
  • MSc in “Pharmaceutical Biotechnology and Biomedicine”
    • Advanced Biotechnology (lectures/seminars, 3h/week)
    • Techniques in Molecular Biology and Biotechnology
    • Molecular Diagnostics
    • Molecular Biology of Cancer
    • Introduction to Biomedical Research
    • Bioinformatics
  • MSC in “Molecular and Clinical Pharmacology”
    • Biochemical Basis of Drug Action
All postgraduate courses include lectures/seminars (3h/week) with the exception of the laboratory course “Techniques in Molecular Biology and Biotechnology” (practical, 45 h/semester).

Professional Affiliations
  • American Association for Cancer Research (AACR)
  • Women in Cancer Research (sponsored by the AACR)
  • European Federation of Biotechnology (EFB)
    • Section of Applied Functional Genomics
    • Associated Section on Pharma-Medical Biotechnology (EAPB)
    • European Association for Pharma Biotechnology (EAPB)
  • International Proteolysis Society
  • The kallikrein Society
  • Hellenic Proteomics Society
  • Hellenic Society of Biochemistry and Molecular Biology
  • Association of Hellenic Chemists
  • Association of Fulbright Scholars

Selected Publications
  1. Pampalakis G, Obasuyi O, Papadodima O, Chatziioannou A, Zoumpourlis V, Sotiropoulou G. (2013) The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway. Oncotarget, Advance Publications 2013
  2. Sotiropoulou G, Pampalakis G. (2012) Targeting the kallikrein-related peptidases for drug development. Trends Pharmacol Sci 33: 623-634.
  3. Sotiropoulou G, Pampalakis G, Prosnikli E, Evangelatos GP, Livaniou E. (2012) Development and immunochemical evaluation of a novel chicken IgY antibody specific for KLK6. Chem Cent J 6: 148.
  4. Chimonidou M, Tzitzira A, Strati A, Sotiropoulou G, Sfikas C, Malamos N, Georgoulias V, Lianidou E. (2012) CST6 promoter methylation in circulating cell-free DNA of breast cancer patients. Clin Biochem 46: 235-240
  5. Kapasa M, Vlachakis D, Kostadima M, Sotiropoulou G, Kossida S. (2012) Towards the elucidation of the regulatory network guiding the insulin producing cells' differentiation. Genomics 100: 212-221.
  6. Chimonidou M, Strati A, Tzitzira A, Sotiropoulou G, Malamos N, Georgoulias V, Lianidou ES. (2011) DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem 57: 1169-1177.
  7. Arnold S, Pampalakis G, Kantiotou K, Silva D, Cortez C, Missailidis S, Sotiropoulou G. (2011) One round of SELEX for the generation of DNA aptamers directed against KLK6. Biol Chem 393: 343-353.
  8. Papanastasiou AD, Pampalakis G, Katsaros D,Sotiropoulou G. . (2011) Netrin-1 overexpression is predictive of ovarian malignancies. Oncotarget 2011 May 2 [Epub ahead of print]
  9. Pavlopoulou A, Pampalakis G, Michalopoulos I, Sotiropoulou G. (2010) Reconstruction of the evolutionary history of tissue kallikreins. PLoS ONE 5: e13781-13781.
  10. Lianidou ES, Mavroudis D, Sotiropoulou G, Aggelaki S, Pantel K. (2010) What’s new on Circulating Tumor Cells? A meeting report. Breast Cancer Res 12: 307-311.
  11. Sotiropoulou G, Pampalakis G. (2010) Evolving concepts of tissue kallikrein-related peptidases as bridges of immune function and proteolytic destruction of extracellular matrix. Biol Chem 391: 321-331.
  12. Sotiropoulou G, Pampalakis G, Diamandis EP. (2009) Functional roles of human kallikrein-related peptidases. J Biol Chem 284: 32989-32994. http://www.jbc.org/site/thematics/proteolytic_enzymes/
  13. Pampalakis G, Diamandis EP, Katsaros D, Sotiropoulou G.(2010) Down-regulation of Dicer mRNA in ovarian cancer tissues provides a new potential biomarker. Clin Biochem 43: 324-327
  14. Pampalakis G, Diamandis EP, Katsaros D, Sotiropoulou G. (2009) Down-regulation of Dicer expression in ovarian cancer tissues. Clin. Biochem. 2009 Sep 24. [Epub ahead of print]
  15. Pampalakis G, Prosnikli E, Agalioti T, Vlahou A, Zoumpourlis V, Sotiropoulou G. (2009) A tumor protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition. Cancer Res. 69: 3779-3787.
  16. Sotiropoulou G, Pampalakis G, Lianidou ES, Mourelatos Z. (2009) Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 15: 1443-1461.
  17. Kioulafa M, Balkouranidou I, Sotiropoulou G, Kaklamanis L, Mavroudis D, Georgoulias V, Lianidou ES. (2009) Methylation of cystatin M promoter in breast cancer is associated with unfavorable prognosis. Int. J. Cancer, in press
  18. Sotiropoulou G , Sommerhoff CP. (2008) Highlight on advances in proteolysis research. Biol. Chem. 389: 967-969.
  19. Pampalakis G, Scorilas A, Sotiropoulou G. (2008) Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer. Clin. Biochem. 41: 591-597
  20. Pampalakis G, Arampatzidou M, Amoutzias G, Kossida S, Sotiropoulou G. (2007) Identification and analysis of mammalian KLK6 orthologue genes for prediction of physiological substrates. Comput. Biol. Chem. 1776: 22-31
  21. Borgoño CA, Gavigan JA, Alves J, Bowles B, Harris JL, Sotiropoulou G, Diamandis EP (2007) Defining the extended substrate specificity of kallikrein 1-related peptidases. Biol. Chem. 388: 1215-1225.
  22. Pampalakis G,Sotiropoulou G. (2007) Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. BBA Reviews on Cancer 1776: 22-31.
  23. Borgoňo C, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Blaber M, Diamandis EP. (2007) A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation: Regulation by lympho-epithelial Kazal-type inhibitor and digestion of desmoglein 1. J. Biol. Chem. 282: 3640-3652.
  24. Shaw JLV, Grass L, Sotiropoulou G, Diamandis EP. (2006) Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids. Clin. Biochem. 40: 104-110.
  25. Borgoňo C, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Blaber M, Diamandis EP. (2006) A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation: Regulation by lympho-epithelial Kazal-type inhibitor and digestion of desmoglein 1. Journal of Biological Chemistry Dec 11 [Epub ahead of print]
  26. Shaw JLV, Grass L, Sotiropoulou G, Diamandis EP. (2006) Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids. Clinical Biochemistry 40: 104-110. Epub 2006 Aug 25
  27. Pampalakis G, Diamandis EP and Sotiropoulou G. (2006) The epigenetic basis for the aberrant expression of kallikreins in human cancers. Biological Chemistry, 387: 795-799.
  28. Michael IP, Pampalakis G, Mikolajczyk SD, Malm J, Sotiropoulou G, Diamandis EP. (2006) Involvement of human kallikrein 5 (hK5) in proteolytic cascade pathway culminating in seminal plasma liquefaction and prostate cancer progression. Journal of Biological Chemistry 281: 12743-12750.
  29. Lundwall Ǻ, Band V, Blaber M, Clements J, Courty Y, Diamandis EP, Fritz H, Lilja H, Malm J, Maltais LJ, Olsson AY, Petraki C, Scorilas A, Sotiropoulou G, Stenman U-H, Stephan C, Talieri M, Yousef GM. (2006) A comprehensive nomenclature for serine proteases with homology to the tissue kallikrein. Biological Chemistry, 387: 637-641.
  30. Pampalakis G, Sotiropoulou G. (2006) Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Biological Chemistry, 387: 773-782.
  31. Sidiropoulos M, Pampalakis G, Sotiropoulou G, Katsaros D, Diamandis EP (2005) Down-Regulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers. Tumor Biology 26: 324-336.
  32. Obiezu CV, Shan SJ, Soosaipillai A, Luo LY, Grass L, Sotiropoulou G, Petraki CD, Papanastasiou PA, Levesque MA, Diamandis EP. (2005) Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids. Clinical Chemistry 51: 1432-1442.
  33. Michael IP, Sotiropoulou G, Pampalakis G, Magklara A, Ghosh M, Wasney G, Diamandis EP. (2005) Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. Journal of Biological Chemistry 280: 14628-14635.
  34. Ghosh MC, Grass L, Soosaipillai A, Sotiropoulou G, Diamandis EP. (2004) Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biology 25: 193-199.
  35. Pampalakis G, Kurlender L, Diamandis EP, Sotiropoulou G. (2004) Cloning and characterization of novel isoforms of the human kallikrein 6 gene. Biochemical and Biophysical Research Communications 320: 54-61.
  36. Bayés A, Tsetsenis T, Ventura S, Avilés FX, Vendrell J, Sotiropoulou G. (2004) Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation. Biological Chemistry 385: 517-524.
  37. Ghosh MC, Grass L, Soosaipillai A, Sotiropoulou G, Diamandis EP. (2004) Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biology 25: 193-199.
  38. Shridhar R, Zhang J, Song J, Booth BA, Kevil CG, Sotiropoulou G, Sloane BF, Keppler D. (2004) Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene 23: 2206-2215.
  39. Magklara A, Mellati AA, Wasney GA, Little SP, Sotiropoulou G, Becker GW, Diamandis EP. (2003) Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors. Biochem Biophys Res Commun 307: 948-955.
  40. Sotiropoulou G, Rogakos V, Tsetsenis T, Pampalakis G, Zafeiropoulos N, Simillides G, Yiotakis A, Diamandis EP. (2003) Emerging interest in the kallikrein gene family for understanding and diagnosing cancer. Oncology Research 13: 381-391.
  41. Kapadia C, Chang A, Sotiropoulou G, Yousef GM, Grass L, Soosaipillai A, Xing X, Howarth DHC, Diamandis EP. (2003) Human kallikrein 13: Production and purification of recombinant protein, monoclonal and polyclonal antibodies and development of a sensitive and specific immunofluorometric assay. Clinical Chemistry 49:77-86.
  42. Gomis-Rüth FX, Bayés A, Sotiropoulou G, Pampalakis G, Tsetsenis T, Vigellas V, Avilés FX, and Coll M. (2002) The structure of prozyme unveils a novel activation mechanism for the human kallikrein family. The Journal of Biological Chemistry 277: 27273-27281.
  43. Lin R, Nagai Y, Sladek R, Bastien Y, Ho J, Petrecca K, Sotiropoulou G, Diamandis EP, Hudson TJ, White JH. (2002) Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signalling on cell proliferation, differentiation, and immune system regulation. Molecular Endocrinology 16: 1243-1256.
  44. Sotiropoulou G, Kono M, Anisowicz A, Stenman G, Tsuji S, Sager R. (2002) Identification and functional characterization of a human GalNAc a2,6-sialyltransferase with altered expression in breast cancer. Molecular Medicine 8: 42-55.
  45. Zeeuwen PL, Van Vlijmen-Willems IM, Jansen BJ, Sotiropoulou G, Curfs JH, Meis JF, Janssen JJ, Van Ruissen F, Schalkwijk J. (2001) Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. Journal of Investigative Dermatology 116: 693-701.
  46. Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, Sotiropoulou G. (2000) Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clinical Biochemistry 33: 369-375.
  47. Dionyssopoulou H, Mouzaki A, Slootstra J, Puijk W, Meloen R, Cordopatis P, Sotiropoulou G. (2000) Synthetic peptides as putative therapeutic agents in transplantation medicine: application of PEPSCAN to the identification of functional sequences in the extracellular domain of the interleukin-2 receptor beta chain (IL-2Rbeta). Journal of Immunological Methods 241: 83-95.
  48. Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP. (1999) Molecular characterization of zyme/protease M/neurosin, a hormonally-regulated kallikrein-like serine protease. Genomics 62: 251-259.
  49. Anisowicz A, Sotiropoulou G, Sager R. (1999) Re-expression of the SPR1 gene in breast carcinomas by phorbol 12-myristate 13-acetate or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter. Molecular Medicine 5: 526-541.
  50. Sotiropoulou G, Anisowicz A, Sager R. (1997) Identification, cloning and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. Journal of Biological Chemistry 272: 903-910.
  51. Stenman G, Astrom AK, Roijer E, Sotiropoulou G, Zhang M, Sager R. (1997) Assignment of a novel cysteine proteinase inhibitor (CST6) to 11q13 by fluorescence in situ hybridization. Cytogenetics and Cell Genetics 76: 45-46.
  52. Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R. (1996) A novel protease homolog diferentially expressed in breast and ovarian cancer. Molecular Medicine 2: 624-636.
  53. Sotiropoulou G, Anisowicz A, Ryan K, Sager R. (1995) Isolation of a novel protease inhibitor involved in breast cancer and senescence». International Journal of Oncology Suppl. 7: 969.
  54. Sager R, Sheng S, Anisowicz A, Sotiropoulou G, Zou Z, Swisshelm K, Hendrix M, Thor A, Ryan K, Rafidi K, Seftor E. (1994) RNA genetics of breast cancer: maspin as a paradigm. Cold Spring Harbor Symposia of Quantitative Biology 59: 537-546.
  55. Sager R, Anisowicz A, Neveu M, Liang P, Sotiropoulou G. (1993) Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene. FASEB Journal 7: 964-970.

ΔΙΑΦΟΡΕΣ ΔΗΜΟΣΙΕΥΣΕΙΣ
Γεωργία Σωτηροπούλου και Γεώργιος Παμπαλάκης (2007)
Πρωτεάσες και αναστολείς: από τη βασική έρευνα στην ανάπτυξη φαρμάκων και μοριακών διαγνωστικών. Φαρμακευτικά Χρονικά τεύχος 18, 26-29.

Patents
  • Anisowicz A, Sager R, Sotiropoulou G. (1998) “Human protease M, a novel serine protease, and its cDNA sequence and diagnostic and therapeutic uses”. PCT Int. Patent, WO 98/11238, 1-92.
  • Sotiropoulou G, Anisowicz A, Sager R. (1997) “Human cystatin M cDNA sequence, recombinant vector, gene regulation in tumor, and cancer diagnosis and therapy”. PCT Int. Patent, WO 97/14797, 1-67.
Submissions to International Databases
(NCBI, http://www.ncbi.nlm.nih.gov)

1. GenBank/EMBL Database
  • DQ641251: Homo sapiens new PSA transcript variant, partial cds LOCUS: DQ641251, 1221 bp mRNA linear PRI 12-JUN-2006
    Pampalakis G, Sotiropoulou G Identification of new PSA isoforms. (Direct Submission, 16-MAY-2006)
  • DQ223012: Homo sapiens kallikrein 6 precursor (KLK6) mRNA, complete cds, alternatively transcript variant 3 LOCUS: DQ223012, 842 bp mRNA linear
    Pampalakis G, Sotiropoulou G Identification of a novel KLK6 transcript variant (Direct Submission, 26-SEP-2005)
  • AY804248: Homo sapiens kallikrein 6 (KLK6) gene, 5’ flanking region LOCUS: AY804248, 319 bp DNA linear
    Sotiropoulou G, Pampalakis G. (Direct Submission, 27-OCT-2004)
  • AY457039: Homo sapiens kallikrein 6-like mRNA, complete cds
    Pampalakis G, Sotiropoulou G Cloning of novel transcript variants of human kallikrein 6/protease M/zyme/neurosin gene (KLK6)
  • AY318867: Homo sapiens kallikrein 6 precursor (KLK6) mRNA, complete cds. LOCUS: AY318867, 1517 bp mRNA linear
    Pampalakis G, Diamandis EP, Sotiropoulou G. Cloning of novel transcript variants of the human kallikrein 6/protease M/zyme/ neurosin gene (KLK6) (Direct Submission, 09-JUN-2003)
  • AY318868: Homo sapiens kallikrein 6-like mRNA, complete LOCUS: AY318868, 820 bp mRNA linear
    Pampalakis G, Diamandis EP, Sotiropoulou G. Cloning of novel transcript variants of the human kallikrein 6/protease M/zyme/ neurosin gene (KLK6) (Direct Submission, 10-JUN-2003)
  • AY318869: Homo sapiens kallikrein 6 precursor (KLK6) mRNA, complete cds.` LOCUS: AY318869, 1503 bp mRNA linear
    Pampalakis G, Diamandis EP, Sotiropoulou G. Cloning of novel transcript variants of the human kallikrein 6/protease M/zyme/ neurosin gene (KLK6) (Direct Submission, 09-JUN-2003)
  • AY318870: Homo sapiens kallikrein 6-like mRNA, complete LOCUS: AY318870, 929 bp mRNA linear
    Pampalakis G, Diamandis EP, Sotiropoulou G. Cloning of novel transcript variants of the human kallikrein 6/protease M/zyme/ neurosin gene (KLK6) (Direct Submission, 10-JUN-2003)
  • NM002774: Homo sapiens kallikrein 6 (neurosin, zyme) (KLK6), mRNA LOCUS: NM002774, 1512 bp, mRNA linear
    Gomis-Ruth FX, Bayes A, Sotiropoulou G, Pampalakis G, Tsetsenis T, Villegas V, Aviles FX, Coll M. (2002)
  • U14550: Human sialyltransferase SThM (sthm) mRNA, complete cds LOCUS: HSU14550, 1908 bp, mRNA
    Sotiropoulou G. (Direct Submission, 07-NOV-1994)
    Sotiropoulou G, Anisowicz A, Sager R. (1994) Isolation and cloning from human mammary epithelial cells of a complete cDNA sequence homologous to other known sialyltransferases.
  • U62800: Homo sapiens cystatin M (CST6) mRNA, complete cds LOCUS: HSU6280, 577 bp mRNΑ
    Sotiropoulou G , Anisowicz A, Sager R. (Direct Submission, 02-JUL-1996)
  • U62801: Human Protease M mRNA, complete cds LOCUS: HSU62801, 1506 bp mRNΑ
    Anisowicz A, Sotiropoulou G, Sager R. (Direct Submission, 02-JUL-1996)
  • AF079516: Homo sapiens small proline-rich protein 1 (SPR1), promoter LOCUS: AF079516, 634 bp DNA
    Anisowicz A, Sotiropoulou G, Sager R. (Direct Submission, 21-JUL-1998)
2. PDB Database
  • 1GVL_A Chain A, Human Prokallikrein 6 (hK6) Prozyme Proprotease M Proneurosin LOCUS: 1GVL_A, 223 aa (Method: X-ray Diffraction) Gomis-Ruth FX, Bayes A, Sotiropoulou G, Pampalakis G, Tsetsenis T, Vigellas V, Aviles FX, Coll M. (Direct Submission, 14-Feb-2002)
MEETINGS-CONFERENCES-WORKSHOPS
  • 5th General Meeting of the International Proteolysis Society (IPS2007)
    Conference and Cultural Center of the University of Patras 20-24 October 2007, Patras, Greece For more information, visit the website of Meeting
  • 2nd International Symposium on Kallikreins
    Petros M. Nomikos Conference Center 16-18 October 2007, Santorini Island, Greece For more information, visit the website of Symposium
  • Satellite Postgraduate Course on «Proteomics: Μethodologies and Αpplications»
    Department of Pharmacy 19 October 2007 Location:Deprtment of Pharmacy, University of Patras, University Campus For more information, visit the website of Meeting
    http://www.ips2007patras.gr/satellite_course_1.php
  • Satellite Postgraduate Course on «Bioinformatics-Computational Methods in Biological Data Mining»
    Department of Pharmacy 19 October 2007 Location: School of Medicine, University of Patras, University Campus For more information, visit the website of Meeting
    http://www.ips2007patras.gr/satellite_course_2.php
  • Satellite Postgraduate Course on «Enzyme Mechanisms and Kinetics»
    Department of Pharmacy 19-20 October 2007 Location: School of Medicine, University of Patras, University Campus For more information, visit the website of Meeting
    http://www.ips2007patras.gr/satellite_course_3.php
  • Workshop of the Hellenic Proteomics Society
    Conference and Cultural Center of the University of Patras 23 May 2006


ΔΗΜΟΣΙΟΤΗΤΑ
O νομπελίστας Aaron Ciechanover στην Πάτρα
Διεθνές Συνέδριο Διοργανώνει το Τμήμα Φαρμακευτικής
Σημαντικό Συνέδριο του Τμήματος Φαρμακευτικής
Ενημερωτικό Φυλλάδιο για διεθνές συνέδριο IPS2007
Η πορεία διοργάνωσης του 33ου Συνεδρίου της FEBS –11ου Συμποσίου της IUBMB
Quick Cuts January February 2008



ΣΥΝΕΔΡΙΑ
7th International Symposium on Minimal Residual Cancer September 16-19, 2009 Athens - Greece www.ismrc2009.org
For further information: Αυτή η διεύθυνση ηλεκτρονικού ταχυδρομείου προστατεύεται από κακόβουλη χρήση. Χρειάζεται να ενεργοποιήσετε την Javascript για να τη δείτε.

Επισκέψεις Καθηγητών
ΔΙΑΚΡΙΣΗ από την Ευρωπαϊκή Αντικαρκινική Εταιρεία

ΔΙΔΑΣΚΑΛΙΑ ΜΑΘΗΜΑΤΩΝ
ΠΡΟΠΤΥΧΙΑΚΟ ΠΡΟΓΡΑΜΜΑ ΣΠΟΥΔΩΝ
Ακαδημαϊκό Έτος 2010-2011 – Χειμερινό Εξάμηνο
Μάθημα : ΦΑΡΜΑΚΕΥΤΙΚΗ ΒΙΟΤΕΧΝΟΛΟΓΙΑ (ΦΠ-416)

Ημέρες και Ώρες Διδασκαλίας:

Δευτέρα  : 9-12 μμ Εργαστήριο
Τρίτη : 11-13 μμ Μάθημα
Τετάρτη : 10-12 μμ Μάθημα και Φροντιστήριο


Ώρες υποδοχής Προπτυχιακών Φοιτητών
Τρίτη 9:30-11:00 πμ 
Πέμπτη 10:30-13:30 π.μ